EN
HI
Bacil Pharma share price chart
Bacil Pharma Share Key Metrics
Volume
2.30 L
Market Cap
22.59 CR
LTQ@LTP
50@38.50
ATP
38.69
Var Margin
25.34 %
Circuit Range
36.47-40.29
Delivery %
60.69 %
Value
88.95 L
ASM/GSM
No
Market Lot
1
Summary
BACPHAR stock price is ₹38.5 as of 13 Jul, 2026. The stock intraday movement has stayed between ₹37.26 and ₹39.89, while Bacil Pharma share price 52 week high low is ₹26.69 & ₹61.80.
In terms of trading activity, BACPHAR share price has recorded a volume of 2,29,906 shares. The Bacil Pharma has a market cap of ₹5890000. The stock’s Average Traded Price (ATP) stands at ₹38.69, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 50 @ ₹38.50.
The Bacil Pharma upper circuit limit is ₹40.29 & The Bacil Pharma lower circuit limit is ₹36.47, with a Value of ₹88.95 L. The Delivery Percentage for the day is 60.69%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Bacil Pharma Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
69.77
Sector P/B
3.23
Sec. Div. Yield
0.53
Bacil Pharma Resistance and Support
Pivot 38.08
Resistance
First Resistance
38.97
Second Resistance
39.59
Third Resistance
40.48
Support
First Support
37.46
Second Support
36.57
Third Support
35.95
Bacil Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-09 | Others |
| 2026-06-26 | Fund Raising & Others |
| 2026-05-22 | Audited Results |
| 2026-02-13 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-09-05 | Others |
| 2025-08-25 | Others |
| 2025-08-12 | Quarterly Results |
| 2025-07-16 | Others |
| 2025-05-26 | Audited Results |
| 2025-01-21 | Quarterly Results |
Bacil Pharma News
Bacil Pharma Ltd - 524516 - Announcement under Regulation 30 (LODR)-Change in Management
Bacil Pharma's board announced the resignation of two independent directors, Mr. Dinesh Chander Notiyal and Ms. Avani Savjibhai Godhaniya. This change affects the board composition.
Jul 09 2026 20:07:32
Bacil Pharma Ltd - 524516 - Announcement under Regulation 30 (LODR)-Raising of Funds
Bacil Pharma's Board approved a Rights Issue to raise up to Rs. 50 crore, a significant fundraise for the micro-cap company. The board also approved an increase in authorised share capital to Rs. 65 crore, pending shareholder approval.
Jul 09 2026 20:06:32
Read More
Bacil Pharma Management
| Name | Position |
|---|---|
| Dinesh Chander Notiyal | Non Executive Independent Director |
| Avani Savjibhai Godhaniya | Non Executive Independent Director |
Bacil Pharma Similar Stocks
Bacil Pharma FAQs
The Buying Price of Bacil Pharma share is 38.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Bacil Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Bacil Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Bacil Pharma shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Bacil Pharma shares is 0. Useful to assess the stock's value relative to its book value.
To assess Bacil Pharma’s valuation compare Sector P/E, P/B which are 69.77 & 3.23 with sector averages, along with growth rates and financial metrics.
The Market Cap of Bacil Pharma is 22.59 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Bacil Pharma share price is 61.80 & 26.69. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Bacil Pharma belongs to the Healthcare sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
